About Mirvie
The Mirvie RNA platform is first to predict unexpected complications before they happen by revealing the underlying biology of each pregnancy
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
South San Francisco, United States
Year Founded
2018
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
mirvie.com
Domain Registered Date
Apr 17, 2019
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $60,000,000 · Series-B+
fundraisingfox.com
- Milestone
X account created (@MirvieDx)
461 followers
- Milestone
Website domain registered
mirvie.com
- Milestone
Company founded
South San Francisco, United States
Investors & Backers
Allyson Felix
BlackRock
Comerica Bank
Correlation Ventures
Decheng Capital
Foresite Capital
General Catalyst
GV
Khosla Ventures
Mayfield Fund
Portfolia
Synetro Group
Funding History
Series-B+
· May 17, 2022
$60,000,000 fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026